Get the latest news on Hangzhou Tigermed stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on HNGZY performance

Latest Hangzhou Tigermed Stock News | OTC:HNGZY | Benzinga

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

HANGZHOU TIGRMD UNSP/ADR by HANGZHOU TIGERMED CONSULTING CO LTD.

Hangzhou Tigermed Consulting Co Ltd

Earnings

Comments

Hangzhou Tigermed Stock News

News

Latest Hangzhou Tigermed Stock News | OTC:HNGZY | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga